Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Asymptomatic primary hyperparathyroidism.

Silverberg SJ, Walker MD, Bilezikian JP.

J Clin Densitom. 2013 Jan-Mar;16(1):14-21. doi: 10.1016/j.jocd.2012.11.005. Review.

2.

Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy.

Gasser RW.

Wien Med Wochenschr. 2013 Sep;163(17-18):397-402. doi: 10.1007/s10354-013-0235-z. Review.

PMID:
23990260
3.

Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.

Lewiecki EM.

J Clin Densitom. 2010 Oct-Dec;13(4):324-34. doi: 10.1016/j.jocd.2010.06.004. Review.

PMID:
21029971
4.

The diagnosis and management of asymptomatic primary hyperparathyroidism.

Silverberg SJ, Bilezikian JP.

Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):494-503. Review.

PMID:
16957763
5.

Nontraditional manifestations of primary hyperparathyroidism.

Walker MD, Rubin M, Silverberg SJ.

J Clin Densitom. 2013 Jan-Mar;16(1):40-7. doi: 10.1016/j.jocd.2012.11.008. Review.

6.

[Primary hyperparathyroidism: new concepts, new recommendations].

Crouzeix G, Kerlan V.

Ann Endocrinol (Paris). 2014 Oct;75 Suppl 1:S21-36. doi: 10.1016/S0003-4266(14)70024-1. French.

PMID:
25617920
7.

Extensive brown tumors caused by parathyroid adenoma in an adolescent patient.

Atabek ME, Pirgon O, Sert A, Esen HH.

Eur J Pediatr. 2008 Jan;167(1):117-9.

PMID:
17273830
8.

Medical management of primary hyperparathyroidism.

Khan AA.

J Clin Densitom. 2013 Jan-Mar;16(1):60-3. doi: 10.1016/j.jocd.2012.11.010. Review.

PMID:
23374743
9.

Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Khan A, Grey A, Shoback D.

J Clin Endocrinol Metab. 2009 Feb;94(2):373-81. doi: 10.1210/jc.2008-1762. Review.

PMID:
19193912
10.

Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review.

Sabbadin C, Donà G, Bordin L, Iacobone M, Camozzi V, Mian C, Armanini D.

BMC Endocr Disord. 2015 Jan 28;15:4. doi: 10.1186/1472-6823-15-4. Review.

11.

Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management.

Pyram R, Mahajan G, Gliwa A.

Maturitas. 2011 Nov;70(3):246-55. doi: 10.1016/j.maturitas.2011.07.021. Review.

PMID:
21943558
12.

An overview of normocalcemic primary hyperparathyroidism.

Pawlowska M, Cusano NE.

Curr Opin Endocrinol Diabetes Obes. 2015 Dec;22(6):413-21. doi: 10.1097/MED.0000000000000198. Review.

PMID:
26512768
13.

Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.

Del Prete M, Marotta V, Ramundo V, Marciello F, Di Sarno A, Esposito R, Carratù AC, De Luca Di Roseto C, Di Somma C, Colao A, Faggiano A.

Minerva Endocrinol. 2013 Dec;38(4):389-94.

PMID:
24285106
14.

Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).

Salinas M, López-Garrigós M, Pomares F, Lugo J, Asencio A, López-Penabad L, Dominguez JR, Leiva-Salinas C.

Bone. 2013 Sep;56(1):73-6. doi: 10.1016/j.bone.2013.05.011.

PMID:
23707628
15.

Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.

Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V.

J Postgrad Med. 2012 Apr-Jun;58(2):107-11. doi: 10.4103/0022-3859.97171.

16.

Primary hyperparathyroidism during pregnancy.

Dochez V, Ducarme G.

Arch Gynecol Obstet. 2015 Feb;291(2):259-63. doi: 10.1007/s00404-014-3526-8. Review.

PMID:
25367603
17.

Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.

Rejnmark L, Amstrup AK, Mollerup CL, Heickendorff L, Mosekilde L.

J Clin Endocrinol Metab. 2013 Jan;98(1):87-96. doi: 10.1210/jc.2012-2499.

PMID:
23150677
18.

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, Dempster D, Lewiecki EM, Liu JM, Minisola S, Rejnmark L, Silva BC, Walker MD, Bilezikian JP.

J Clin Endocrinol Metab. 2014 Oct;99(10):3580-94. doi: 10.1210/jc.2014-1415.

PMID:
25162667
19.

Hyperparathyroidism: primary or secondary disease?

Cordellat IM.

Reumatol Clin. 2012 Sep-Oct;8(5):287-91. Review.

20.

Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years.

Shah VN, Bhadada S, Bhansali A, Behera A, Mittal BR.

Indian J Med Res. 2014 May;139(5):694-9.

Items per page

Supplemental Content

Support Center